Find your next paid study

University of California, IrvineNCT06338475

Colorectal CancerPancreatic CancerEsophageal Cancer+1 more

Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

The overall goal of this feasibility study is to assess the initial safety and efficacy of LUM015 in ex vivo far-red imaging of colorectal, pancreatic, and eso…

Lumicell, Inc.NCT02584244

~$10 – $8,750

Pediatric CancerMalnutrition, ChildCaregiver Burden

From Kitchen to Clinic: A Family-Centered, Food-As-Medicine Approach Using Medically Tailored Meals and Caregiver Coaching in Pediatric Oncology Care

Children receiving cancer treatment often experience nutrition-related challenges, such as changes in appetite, weight, and food intake, due to treatment side …

Drexel UniversityNCT07454902

Home Air Radon TestingLung Cancer

Co-developing and Pilot Testing a Risk-tailored, Technology-supported Intervention to Increase Home Radon Testing in New Hampshire and Vermont

This study is about home air radon testing and has two phases. The goal of the first phase is to learn about renters' and homeowners' views and plans related …

Dartmouth-Hitchcock Medical CenterNCT05833334

Lung CancerLung Neoplasm MalignantCarcinoma, Non-Small-Cell Lung+1 more

Bronchoscopy With and Without Needle-based Confocal Laser Endomicroscopy for Peripheral Lung Nodule Diagnosis: Protocol for a Multicenter Randomized Controlled Trial (CLEVER Trial)

The goal of this multi-center randomized clinical trial is to evaluate the added value of needle based confocal laser endomicroscopy (nCLE)-imaging to regular …

Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)NCT06079970

AI-Driven Early Detection of Cachexia in Pancreatic Cancer and Feasibility of Diet and Exercise Interventions

This observational study aims to (1) validate a multimodal artificial intelligence (AI) model for early detection of cancer-associated cachexia in pancreatic c…

Pancreatic CancerCancer Cachexia

H. Lee Moffitt Cancer Center and Research InstituteNCT07249775

~$10 – $750

Epithelial Ovarian CancerGastro-esophageal Junction CancerSoft Tissue Sarcoma (STS)+2 more

EPITOME-1015-I: a Phase I Study to Investigate the Safety, Tolerability and Preliminary Efficacy of a Third Generation TCR-T Therapy, MDG1015, in Epithelial Ovarian Carcinoma, Gastroesophageal (Junction) Adenocarcinoma, Myxoid (Round Cell) Liposarcoma And/or Synovial Sarcoma Subjects with Advanced Disease Expressing NY-ESO-1 And/or LAGE-1a

MDG1015 is a third generation TCR-T therapy product targeting NY-ESO-1/LAGE-1a armored and enhanced by the PD1-41BB costimulatory switch protein (CSP). The stu…

~$10 – $8,750

Medigene AGNCT06748872

Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision

Building upon prior work, the investigator team developed a communication intervention for older adults with ADRD who are considering a decision about cancer m…

CancerDementia

University of RochesterNCT06313853

Cleveland African American Prostate Cancer Project: Equivalence of Passive Navigation, Active Navigation, and Community-based Screening for Completion of Prostate Cancer Screening

The purpose of this research is to test intervention strategies that encourage and support Black or African American men who are 40 and older to complete prost…

Prostate Cancer

Case Comprehensive Cancer CenterNCT05469269

Prostate Cancer (Adenocarcinoma)

High Dose Rate Brachytherapy Prior to Robotic Assisted Laparoscopic Prostatectomy With Selective Adjuvant Androgen Blockade for Localized High-risk Prostate Cancer (NEOHDR-B)

This is a Phase I/II trial evaluating the effectiveness of adding neoadjuvant HDR-B prior to RALP for HR-PCa patients with selective AAB for decipher high risk…

The Methodist Hospital Research InstituteNCT07182279

A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical resear…

Sanguine BiosciencesNCT05635266

~$10 – $1,050

HR+/HER2-negative Breast Cancer

A Study to Evaluate the Safety and Tolerability of the Covalent Phosphoinositide-3-Kinase (PI3K)-Alpha Inhibitor, TOS-358, in Adult Subjects With Select Solid Tumors

The goal of this clinical trial is to evaluate the safety and efficacy of TOS-358 in women with HR+ HER2- metastatic breast cancer whose tumors have a mutation…